Study of ONO-8577 in Patients With Overactive Bladder
Status:
Completed
Trial end date:
2017-09-26
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the efficacy and safety of ONO-8577 compared to
combination of solifenacin succinate and mirabegron or placebo for overactive bladder